Published on in Vol 9 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/45263, first published .
Safety Signal Generation for Sudden Sensorineural Hearing Loss Following Messenger RNA COVID-19 Vaccination: Postmarketing Surveillance Using the French Pharmacovigilance Spontaneous Reporting Database

Safety Signal Generation for Sudden Sensorineural Hearing Loss Following Messenger RNA COVID-19 Vaccination: Postmarketing Surveillance Using the French Pharmacovigilance Spontaneous Reporting Database

Safety Signal Generation for Sudden Sensorineural Hearing Loss Following Messenger RNA COVID-19 Vaccination: Postmarketing Surveillance Using the French Pharmacovigilance Spontaneous Reporting Database

Journals

  1. Reynard P, Thai-Van H. Drug-induced hearing loss: Listening to the latest advances. Therapies 2024;79(2):283 View
  2. Liew X, Tang Z, Ong Y, See K. Hearing Loss after COVID-19 and Non-COVID-19 Vaccination: A Systematic Review. Vaccines 2023;11(12):1834 View
  3. Thai-Van H, Bagheri H, Valnet-Rabier M. Sudden Sensorineural Hearing Loss after COVID-19 Vaccination: A Review of the Available Evidence through the Prism of Causality Assessment. Vaccines 2024;12(2):181 View
  4. . Elasomeran/tozinameran. Reactions Weekly 2024;2000(1):153 View
  5. Skare T, de Carvalho J, de Medeiros I, Shoenfeld Y. Ear abnormalities in chronic fatigue syndrome (CFS), fibromyalgia (FM), Coronavirus-19 infectious disease (COVID) and long-COVID syndrome (PCS), sick-building syndrome (SBS), post-orthostatic tachycardia syndrome (PoTS), and autoimmune/inflammatory syndrome induced by adjuvants (ASIA): A systematic review. Autoimmunity Reviews 2024;23(10):103606 View

Books/Policy Documents

  1. Morgan A, Bosak J, Hagenstein L, Ambler A, Brooks B. . View